Swati Bhayana Leads Breakthrough Pediatric Sickle Cell Cure in India
Swati Bhayana, Consultant at Fortis Healthcare, shared a post by Biomall.in on LinkedIn:
”Gratitude to the amazing team of doctors, nurses, hospital management who supported endlessly for the dream
– We are the force.”
Quoting Biomall.in’s post:
”Hope for Sickle Cell: A Breakthrough in India’s Pediatric Care
India marks a major milestone in the fight against Sickle Cell Disease (SCD) with a decade-long clinical study demonstrating the transformative potential of pediatric stem-cell transplantation.
Led by Dr. SWATI BHAYANA, a leading pediatric hematologist at Fortis Healthcare Gurugram, the team has reported remarkable outcomes:~87% overall survival rate among children undergoing stem-cell transplant 96% survival when the donor is a matched sibling, Significant reduction in long-term complications, and improved quality of life
This achievement brings India closer to offering globally benchmarked curative therapy, especially critical for high-burden tribal and underserved regions. It underscores the power of clinical innovation, strong donor-matching programs, and advanced transplant care in reshaping SCD management.
Read the full article here.”
Title: Indian Healthcare Achieves Global Standards in Pediatric SCD Cure
Stay informed with Hemostasis Today.
-
Feb 23, 2026, 18:13Fight4Hematology Supports Research and Empowers the Next Generation – ASH
-
Feb 23, 2026, 17:59Wolfgang Miesbach: Real-World Evidence of Emicizumab on Joint Outcomes in Hemophilia A
-
Feb 23, 2026, 17:56Shiny K Kajal: The Transfusion Reaction We Often Miss
-
Feb 23, 2026, 17:53Radheshyam Meher: Contributing to the Transfusion Evidence Round-Up for International Childhood Cancer Day 2026
-
Feb 23, 2026, 17:46Mahesan Subramaniam: The Physiological Impact of Anger on Immunity
-
Feb 23, 2026, 17:42Bryan Fry: First Evidence That Bothrops atrox Venom Directly Activates Human Factor VII
-
Feb 23, 2026, 17:34Bastu Odoka: Why Blood Should NOT be Left at the Bedside to ‘Warm’
-
Feb 23, 2026, 17:28Henry Burkitt: Patients Are Challenging How the Medicines Policy System Works in England
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch